CAS 105565-56-8 BMY-14802 - Analytical Products / Alfa Chemistry

1

BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia

G R Gewirtz, J M Gorman, J Volavka, J Macaluso, G Gribkoff, D P Taylor, R Borison

Neuropsychopharmacology. 1994 Feb;10(1):37-40.

PMID: 7910021

1

BMY-14802 Reversed the Sigma Receptor Agonist-Induced Neck Dystonia in Rats

K Okumura, H Ujike, K Akiyama, S Kuroda

J Neural Transm (Vienna). 1996;103(10):1153-61.

PMID: 9013402

1

The Effects of BMY-14802 Against L-DOPA- And Dopamine Agonist-Induced Dyskinesia in the Hemiparkinsonian Rat

Nirmal Bhide, David Lindenbach, Margaret A Surrena, Adam A Goldenberg, Christopher Bishop, S Paul Berger, Melanie A Paquette

Psychopharmacology (Berl). 2013 Jun;227(3):533-44.

PMID: 23389756

1

The Sigma Receptor Ligand (+/-)-BMY 14802 Prevents Methamphetamine-Induced Dopaminergic Neurotoxicity via Interactions at Dopamine Receptors

I Terleckyj, P K Sonsalla

J Pharmacol Exp Ther. 1994 Apr;269(1):44-50.

PMID: 7513362

1

The sigma-1 Antagonist BMY-14802 Inhibits L-DOPA-induced Abnormal Involuntary Movements by a WAY-100635-sensitive Mechanism

Melanie A Paquette, Katherine Foley, Elizabeth G Brudney, Charles K Meshul, Steven W Johnson, S Paul Berger

Psychopharmacology (Berl). 2009 Jul;204(4):743-54.

PMID: 19283364